Nancy Jean Cox to Drug-Related Side Effects and Adverse Reactions
This is a "connection" page, showing publications Nancy Jean Cox has written about Drug-Related Side Effects and Adverse Reactions.
Connection Strength
0.910
-
Pharmacogenomic variants have larger effect sizes than genetic variants associated with other dichotomous complex traits. Pharmacogenomics J. 2016 08; 16(4):388-92.
Score: 0.390
-
DDIWAS: High-throughput electronic health record-based screening of drug-drug interactions. J Am Med Inform Assoc. 2021 07 14; 28(7):1421-1430.
Score: 0.148
-
High-throughput framework for genetic analyses of adverse drug reactions using electronic health records. PLoS Genet. 2021 06; 17(6):e1009593.
Score: 0.147
-
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat. 2020 Jun; 181(3):623-633.
Score: 0.136
-
Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci. Proc Natl Acad Sci U S A. 2010 May 18; 107(20):9287-92.
Score: 0.068
-
The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics. Clin Pharmacol Ther. 2012 Oct; 92(4):446-9.
Score: 0.020